跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ilumya
Approved
STANDARD
Ilumya
Vetter Pharma-Fertigung GmbH & Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9b440a5f28207f8d
Company
Vetter Pharma-Fertigung GmbH & Co. KG
Type
Standard
Approval Details
Approval Id
9b440a5f28207f8d
Drug Approval Philippines Name
Ilumya
Product Name
Ilumya
Registration Number
BR-1419
Brand Name
Ilumya
Generic Name
Tildrakizumab
Dosage Form
Solution for Injection (S.C.)
Dosage Strength
100 mg/mL
Manufacturer
Vetter Pharma-Fertigung GmbH & Co. KG
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Issuance Date
24 May 2024
Expiry Date
13 September 2027
Pharmacologic Category
Interleukin Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9b440a5f28207f8d
Type
Standard
Back to Philippines FDA Approvals
Ilumya - Philippines FDA Drug Approval Details